Stellate Ganglion Block for Long COVID Symptom Management: A Case Report
Mashfee H Khan, Kennedy P Kirkpatrick, Yi Deng, Krishna B Shah, Mashfee H Khan, Kennedy P Kirkpatrick, Yi Deng, Krishna B Shah
Abstract
Stellate ganglion block (SGB) is gaining increasing acceptance as a treatment modality for various medical conditions. It works by blocking neuronal transmissions which in turn alleviates sympathetically-driven disease processes. Many of the prolonged sequelae of long COVID are thought to be mediated by dysregulation of the autonomic nervous system, and SGB is being investigated as a potential option for symptomatic management of long COVID. This case report demonstrates the efficacy of SGB in a previously healthy patient for the management of long COVID symptoms including fatigue, post-exertional malaise, shortness of breath, and gastrointestinal symptoms. .
Keywords: chronic fatigue; covid 19; long-covid; stellate ganglion; stellate ganglion block.
Conflict of interest statement
The authors have declared that no competing interests exist.
Copyright © 2022, Khan et al.
Figures
References
- Sequelae in Adults at 6 Months After COVID-19 Infection. Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY. JAMA Netw Open. 2021;4:0.
- Piraccini E, Munakomi S, Chang KV. StatPearls. Treasure Island, FL: StatPearls Publishing; 2022. Stellate Ganglion Blocks.
- Orthostatic symptoms and reductions in cerebral blood flow in long-haul COVID-19 patients: similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Campen CL, Rowe PC, Visser FC. Medicina (Kaunas) 2021;58:28.
- Stellate ganglion block reduces symptoms of Long COVID: A case series. Liu LD, Duricka DL. J Neuroimmunol. 2022;362:577784.
- Reflex control of immunity. Tracey KJ. Nat Rev Immunol. 2009;9:418–428.
- From inflammation to sickness and depression: when the immune system subjugates the brain. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. Nat Rev Neurosci. 2008;9:46–56.
- COVID-19 related olfactory dysfunction. Karamali K, Elliott M, Hopkins C. Curr Opin Otolaryngol Head Neck Surg. 2022;30:19–25.
- The temporal course of COVID-19 anosmia and relation to other clinical symptoms. Altundag A, Saatci O, Sanli DE, et al. Eur Arch Otorhinolaryngol. 2021;278:1891–1897.
- Stellate ganglion block for anosmia and dysgeusia due to Long COVID. Chauhan G, Upadhyay A, Khanduja S, Emerick T. Cureus. 2022;14:0.
- The optimal volume of 0.2% ropivacaine required for an ultrasound-guided stellate ganglion block. Jung G, Kim BS, Shin KB, Park KB, Kim SY, Song SO. Korean J Anesthesiol. 2011;60:179–184.
- Stellate ganglion blockade for treating refractory electrical storm: a historical cohort study. Reinertsen E, Sabayon M, Riso M, Lloyd M, Spektor B. Can J Anaesth. 2021;68:1683–1689.
- Ultrasound-guided bilateral stellate ganglion blockade to treat digital ischemia in a patient with sepsis: a case report. Bataille B, Nucci B, Mora M, Silva S, Cocquet P. Can J Anaesth. 2016;63:56–60.
- Pain management of the oncologic patient. Arter OE, Racz GB. Semin Surg Oncol. 1990;6:162–172.
- Stellate ganglion local anesthetic blockade and neurolysis for the treatment of refractory ventricular fibrillation. Hulata DF, Le-Wendling L, Boezaart AP, Hurley RW. A A Case Rep. 2015;4:49–51.
Source: PubMed